Jan 5 |
Personalis forecasts upbeat Q4 revenue outlook
|
Jan 5 |
Personalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash Balance
|
Dec 21 |
Personalis files for $200M mixed shelf
|
Dec 18 |
Even With A 37% Surge, Cautious Investors Are Not Rewarding Personalis, Inc.'s (NASDAQ:PSNL) Performance Completely
|
Dec 4 |
Personalis expects workforce reduction to extend cash runway into 2026
|
Dec 4 |
Personalis Extends Cash Position Into 2026, Provides Update on Key Initiatives
|
Dec 1 |
Cancer test developer Personalis to cut 65 jobs to reduce costs
|
Nov 29 |
Personalis to issue 9.2M shares as Tempus joins hands for cancer test
|
Nov 28 |
Personalis and Tempus Enter into a Strategic Collaboration to Advance Cancer Testing
|
Nov 16 |
Meet the biotech company Cathie Wood bought half a million shares of this month
|